Etanercept

ATC Code L04AB01

Etanercept

Definition

A recombinant soluble dimeric fusion protein consisting of the extracellular ligand-binding region of recombinant human tumor necrosis factor (rhTNF) receptor attached to the constant (Fc) region of human immunoglobulin G (FcIgG). The receptor moiety of etanercept binds to circulating TNF (2 molecules of TNF per receptor) and inhibits its attachment to endogenous TNF cell surface receptors, thereby rendering TNF inactive and inhibiting TNF-mediated mechanisms of inflammation. (NCI04)

Also known as Enbrel, ETANERCEPT, TNFR:Fc, Tumor Necrosis Factor Receptor IgG Chimera — per NCIT

Also identified as

Indications

Disease Relation Source
Ankylosing spondylitis may treat MEDRT · Public domain (U.S. Government work)
Juvenile idiopathic arthritis may treat MEDRT · Public domain (U.S. Government work)
Psoriatic arthritis may treat MEDRT · Public domain (U.S. Government work)
Rheumatoid arthritis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Bone element may treat a disease of this organ DERIVED · CC BY 4.0
Musculoskeletal system may treat a disease of this organ DERIVED · CC BY 4.0
Skeletal joint may treat a disease of this organ DERIVED · CC BY 4.0

3 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.